Drugs

(asked on 11th May 2018) - View Source

Question to the Department of Health and Social Care:

To ask the Secretary of State for Health and Social Care, what savings has been generated for the public purse through managed access agreements for new medicines since 2016.


Answered by
Steve Brine Portrait
Steve Brine
This question was answered on 21st May 2018

The Department has made no estimate of savings generated across all agreements. NHS England estimates that in the period from 31 July 2016 to 31 April 2018, Managed Access Agreements for 15 drug indications put in place as part of the Cancer Drugs Fund have collectively generated approximately £41 million of discounts when compared with the price originally offered by companies. It is also estimated by NHS England that savings to the overall National Health Service budget arising from similar recent agreements is in excess of £50 million per year.

Reticulating Splines